Danny Zanardo, Chief Commercial Officer
Danny has over 25 years of commercial experience in Australian and global pharmaceuticals and medical devices. He has held executive positions in both private and ASX listed entities including Admedus Ltd, Roche and Actelion with a track record of successfully commercialising new medical technologies in Europe, North America, Asia Pacific and MENA.Chief Commercial Officer
Jacques Schipper, Chief Financial Officer
Jacques brings over 14 years of experience in Finance, Commercial Management & Controller roles. Prior to LTP he has been in senior financial roles at Lion Dairy & Drinks, Anteris Technologies, NL Food, First Quantum Minerals as well having successfully owned and managed several private businesses.
Peter McLennan, Chief Operating Officer
Peter has worked with companies of all sizes worldwide to improve operations and technology and engage with the financial markets. Peter has advised large European enterprises, Australian and New Zealand startups, and Australian government agencies. Peter has also served as a Non-Executive Director on an ASX board for a technology company, bringing valuable insights into governance and strategic direction. Furthermore, Peter worked in London for a US investment bank and as a consultant to Life Science, Agricultural, Industrial, and Technology companies in Australia, giving him extensive financial markets and M&A experience.
Mike Sweeting, VP, US Sales & Marketing
Mike has over 30 years of senior leadership roles in the pharmaceutical industry in commercial sales and market access. Mike currently serves early-stage pharmaceutical and biotech companies as an executive management consultant, most recently, building all functions related to Market Access for Scilex Pharmaceuticals, a San Diego-based startup.
Kip Vought, VP, Regulatory
Kip is a senior pharmaceutical R&D and regulatory executive with over 25 years of experience across major global markets. Successful leadership in preparation of agency meetings (PIND and equivalent, EOP1, EOP2, and PNDA/MAA and regional equivalents) all the way through to the preparation and submission of market applications.
